top of page

Home: Welcome
We are a start-up committed to the use of precision medicine to help streamline treatment for ADHD.
We use AI methods to map together elements, including clinical factors, genes and environment. We transform multi-dimensional data into prediction models of which treatment plan is likely to work best for each individual.
AI for Mental Health
Home: Contact
AIMH in print
First Post article:
Unravelling the complexity of ADHD, by Mel Lefebvre and Sarojini Sengupta. Read it here.


News18 article on the risks of ADHD in women and girls, by Communications Director Mel and CEO Sarojini. Read it here.
First Post article on ADHD awareness, by Communications Director Mel and CEO Sarojini. Read it here.
CADDRA ADHD Research Digest
Issue 5, March 2022. ; Click to read the article by CSO Tyler Bonnell and CEO Sarojini Sengupta; Visit here to watch the interview.

bottom of page


